• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

厄贝沙坦可预防犬心房颤动模型中的钠通道重塑。

Irbesartan prevents sodium channel remodeling in a canine model of atrial fibrillation.

作者信息

Wang Xuewen, Li Guangping

机构信息

Tianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular Disease, Department of Cardiology, Tianjin Institute of Cardiology, Second Hospital of Tianjin Medical University, China.

出版信息

J Renin Angiotensin Aldosterone Syst. 2018 Jan-Mar;19(1):1470320318755269. doi: 10.1177/1470320318755269.

DOI:10.1177/1470320318755269
PMID:29378480
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5843850/
Abstract

INTRODUCTION

Activation of the renin-angiotensin system (RAS) plays an important role in atrial electrical remodeling (AER). The purpose of the present study was to evaluate the effects of irbesartan on cardiac sodium current (I) in a canine model of atrial fibrillation.

MATERIALS AND METHODS

Eighteen dogs were randomized into sham, pacing or pacing+irbesartan groups ( n = 6 in each group). The dogs in the pacing and irbesartan group were paced at 500 bpm for two weeks. Irbesartan (60 mg·kg·d) was administered orally in the pacing+irbesartan groups. I was recorded using the whole-cell patch clamp technique from canine atrial myocytes. The expressions of cardiac Na channels (Nav1.5) mRNA were semi-quantified by reverse transcription-polymerase chain reaction.

RESULTS

Our results showed that I density and Nav1.5 mRNA expression in the pacing group decreased significantly ( p < 0.05 vs. sham). However, rapid atrial pacing had no effects on the half-activation voltage (V) and half-inactivation voltage (V) of I ( p > 0.05 vs. sham). Irbesartan significantly increased I densities and gene expression and hyperpolarized V without concomitant changes in V.

CONCLUSIONS

Irbesartan significantly increased I densities, which contributed to improving intra-atrial conduction and prevented the induction and promotion of AF in atrial pacing dogs.

摘要

引言

肾素-血管紧张素系统(RAS)的激活在心房电重构(AER)中起重要作用。本研究旨在评估厄贝沙坦对犬心房颤动模型中心脏钠电流(I)的影响。

材料与方法

18只犬被随机分为假手术组、起搏组或起搏+厄贝沙坦组(每组n = 6)。起搏组和厄贝沙坦组的犬以500次/分钟的频率起搏两周。起搏+厄贝沙坦组口服厄贝沙坦(60mg·kg·d)。采用全细胞膜片钳技术记录犬心房肌细胞的I。通过逆转录-聚合酶链反应对心脏钠通道(Nav1.5)mRNA的表达进行半定量分析。

结果

我们的结果显示,起搏组的I密度和Nav1.5 mRNA表达显著降低(与假手术组相比,p < 0.05)。然而,快速心房起搏对I的半激活电压(V)和半失活电压(V)没有影响(与假手术组相比,p > 0.05)。厄贝沙坦显著增加了I密度和基因表达,并使V超极化,而V没有随之改变。

结论

厄贝沙坦显著增加了I密度,这有助于改善心房内传导,并预防心房起搏犬房颤的诱发和进展。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f14a/5843850/8ef757a3dbd1/10.1177_1470320318755269-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f14a/5843850/461530eda64e/10.1177_1470320318755269-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f14a/5843850/3643f9223694/10.1177_1470320318755269-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f14a/5843850/c026a9c8ab39/10.1177_1470320318755269-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f14a/5843850/8ef757a3dbd1/10.1177_1470320318755269-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f14a/5843850/461530eda64e/10.1177_1470320318755269-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f14a/5843850/3643f9223694/10.1177_1470320318755269-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f14a/5843850/c026a9c8ab39/10.1177_1470320318755269-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f14a/5843850/8ef757a3dbd1/10.1177_1470320318755269-fig4.jpg

相似文献

1
Irbesartan prevents sodium channel remodeling in a canine model of atrial fibrillation.厄贝沙坦可预防犬心房颤动模型中的钠通道重塑。
J Renin Angiotensin Aldosterone Syst. 2018 Jan-Mar;19(1):1470320318755269. doi: 10.1177/1470320318755269.
2
Angiotensin-(1-7) prevent atrial tachycardia induced sodium channel remodeling.血管紧张素 -(1 - 7)可预防心房性心动过速诱导的钠通道重塑。
Pacing Clin Electrophysiol. 2014 Oct;37(10):1349-56. doi: 10.1111/pace.12427. Epub 2014 May 23.
3
Enalapril, irbesartan, and angiotensin-(1-7) prevent atrial tachycardia-induced ionic remodeling.依那普利、厄贝沙坦和血管紧张素-(1-7)可预防房性心动过速引起的离子重构。
Int J Cardiol. 2011 Feb 3;146(3):364-70. doi: 10.1016/j.ijcard.2009.07.015. Epub 2009 Sep 3.
4
Effects of irbesartan on gene expression revealed by transcriptome analysis of left atrial tissue in a porcine model of acute rapid pacing in vivo.依贝沙坦对猪体内急性快速起搏模型左心房组织转录组分析揭示的基因表达的影响。
Int J Cardiol. 2013 Oct 3;168(3):2100-8. doi: 10.1016/j.ijcard.2013.01.007. Epub 2013 Feb 12.
5
The potential role of atrial natriuretic peptide in the effects of Angiotensin-(1-7) in a chronic atrial tachycardia canine model.心房利钠肽在慢性房性心动过速犬模型中对血管紧张素-(1-7)作用的潜在作用。
J Renin Angiotensin Aldosterone Syst. 2016 Mar 23;17(1):1470320315627409. doi: 10.1177/1470320315627409. Print 2016 Jan-Mar.
6
The effects of cilazapril and valsartan on the mRNA and protein expressions of atrial calpains and atrial structural remodeling in atrial fibrillation dogs.西拉普利和缬沙坦对心房颤动犬心房钙蛋白酶mRNA和蛋白表达及心房结构重塑的影响
Basic Res Cardiol. 2007 May;102(3):245-56. doi: 10.1007/s00395-007-0641-8. Epub 2007 Feb 2.
7
Effect of irbesartan on development of atrial fibrosis and atrial fibrillation in a canine atrial tachycardia model with left ventricular dysfunction, association with p53.厄贝沙坦对伴有左心室功能障碍的犬房性心动过速模型中房纤维化和心房颤动发展的影响及其与p53的关系
Heart Vessels. 2016 Dec;31(12):2053-2060. doi: 10.1007/s00380-016-0853-7. Epub 2016 May 28.
8
Cilostazol ameliorates atrial ionic remodeling in long-term rapid atrial pacing dogs.西洛他唑改善长期快速心房起搏犬的心房离子重塑。
Anatol J Cardiol. 2015;15(12):963-9. doi: 10.5152/akd.2014.5962. Epub 2014 Nov 11.
9
Blockade of angiotensin II improves hyperthyroid induced abnormal atrial electrophysiological properties.血管紧张素 II 的阻断可改善甲状腺功能亢进引起的异常心房电生理特性。
Regul Pept. 2011 Aug 8;169(1-3):31-8. doi: 10.1016/j.regpep.2011.04.008. Epub 2011 May 3.
10
Protective effects of aliskiren on atrial ionic remodeling in a canine model of rapid atrial pacing.阿利吉仑对快速心房起搏犬模型心房离子重构的保护作用。
Cardiovasc Drugs Ther. 2014 Apr;28(2):137-43. doi: 10.1007/s10557-014-6509-x.

引用本文的文献

1
The Role of Renin-Angiotensin-Aldosterone System in the Heart and Lung: Focus on COVID-19.肾素-血管紧张素-醛固酮系统在心脏和肺部中的作用:聚焦于2019冠状病毒病
Front Pharmacol. 2021 Apr 20;12:667254. doi: 10.3389/fphar.2021.667254. eCollection 2021.
2
On the Rational Drug Design for Hypertension through NMR Spectroscopy.基于 NMR 光谱的高血压合理药物设计。
Molecules. 2020 Dec 22;26(1):12. doi: 10.3390/molecules26010012.
3
Do age-associated changes of voltage-gated sodium channel isoforms expressed in the mammalian heart predispose the elderly to atrial fibrillation?

本文引用的文献

1
Effect of irbesartan on development of atrial fibrosis and atrial fibrillation in a canine atrial tachycardia model with left ventricular dysfunction, association with p53.厄贝沙坦对伴有左心室功能障碍的犬房性心动过速模型中房纤维化和心房颤动发展的影响及其与p53的关系
Heart Vessels. 2016 Dec;31(12):2053-2060. doi: 10.1007/s00380-016-0853-7. Epub 2016 May 28.
2
Angiotensin-Receptor Blocker, Angiotensin-Converting Enzyme Inhibitor, and Risks of Atrial Fibrillation: A Nationwide Cohort Study.血管紧张素受体阻滞剂、血管紧张素转换酶抑制剂与心房颤动风险:一项全国性队列研究
Medicine (Baltimore). 2016 May;95(20):e3721. doi: 10.1097/MD.0000000000003721.
3
哺乳动物心脏中表达的电压门控钠通道亚型的年龄相关变化会使老年人易患心房颤动吗?
World J Cardiol. 2020 Apr 26;12(4):123-135. doi: 10.4330/wjc.v12.i4.123.
4
Anti-arrhythmic properties of non-antiarrhythmic medications.非抗心律失常药物的抗心律失常作用。
Pharmacol Res. 2020 Jun;156:104762. doi: 10.1016/j.phrs.2020.104762. Epub 2020 Mar 23.
5
Angiotensin II and angiotensin 1-7: which is their role in atrial fibrillation?血管紧张素 II 和血管紧张素 1-7:它们在心房颤动中的作用是什么?
Heart Fail Rev. 2020 Mar;25(2):367-380. doi: 10.1007/s10741-019-09837-7.
6
Activin Receptor-Like Kinase 4 Haplodeficiency Mitigates Arrhythmogenic Atrial Remodeling and Vulnerability to Atrial Fibrillation in Cardiac Pathological Hypertrophy.激活素受体样激酶 4 单倍体缺失减轻心脏病理性肥大中的致心律失常性心房重构和心房颤动易感性。
J Am Heart Assoc. 2018 Aug 21;7(16):e008842. doi: 10.1161/JAHA.118.008842.
Angiotensin-(1-7) prevent atrial tachycardia induced sodium channel remodeling.
血管紧张素 -(1 - 7)可预防心房性心动过速诱导的钠通道重塑。
Pacing Clin Electrophysiol. 2014 Oct;37(10):1349-56. doi: 10.1111/pace.12427. Epub 2014 May 23.
4
Irbesartan-mediated AT1 receptor blockade attenuates hyposmotic-induced enhancement of I Ks current and prevents shortening of action potential duration in atrial myocytes.厄贝沙坦介导的AT1受体阻断可减弱低渗诱导的IKs电流增强,并防止心房肌细胞动作电位时程缩短。
J Renin Angiotensin Aldosterone Syst. 2014 Dec;15(4):341-7. doi: 10.1177/1470320312474855. Epub 2013 Feb 5.
5
The angiotensin receptor blocker and PPAR-γ agonist, telmisartan, delays inactivation of voltage-gated sodium channel in rat heart: novel mechanism of drug action.血管紧张素受体阻断剂和过氧化物酶体增殖物激活受体 γ 激动剂替米沙坦延缓大鼠心脏电压门控钠离子通道失活:药物作用的新机制。
Pflugers Arch. 2012 Dec;464(6):631-43. doi: 10.1007/s00424-012-1170-3. Epub 2012 Oct 17.
6
Angiotensin-(1-7) prevents atrial fibrosis and atrial fibrillation in long-term atrial tachycardia dogs.血管紧张素 -(1 - 7)可预防长期房性心动过速犬的心房纤维化和心房颤动。
Regul Pept. 2010 Jun 8;162(1-3):73-8. doi: 10.1016/j.regpep.2009.12.020. Epub 2010 Jan 13.
7
Enalapril, irbesartan, and angiotensin-(1-7) prevent atrial tachycardia-induced ionic remodeling.依那普利、厄贝沙坦和血管紧张素-(1-7)可预防房性心动过速引起的离子重构。
Int J Cardiol. 2011 Feb 3;146(3):364-70. doi: 10.1016/j.ijcard.2009.07.015. Epub 2009 Sep 3.
8
Inhibitory effects of tetrandrine on the Na(+) channel of human atrial fibrillation myocardium.粉防己碱对人房颤心肌钠通道的抑制作用。
Acta Pharmacol Sin. 2009 Feb;30(2):166-74. doi: 10.1038/aps.2008.23. Epub 2009 Jan 19.
9
NF-kappaB-dependent transcriptional regulation of the cardiac scn5a sodium channel by angiotensin II.血管紧张素II对心脏scn5a钠通道的核因子κB依赖性转录调控
Am J Physiol Cell Physiol. 2008 Jan;294(1):C372-9. doi: 10.1152/ajpcell.00186.2007. Epub 2007 Nov 21.
10
Angiotensin-converting enzyme 2 and angiotensin-(1-7): an evolving story in cardiovascular regulation.血管紧张素转换酶2与血管紧张素-(1-7):心血管调节领域的新进展
Hypertension. 2006 Mar;47(3):515-21. doi: 10.1161/01.HYP.0000196268.08909.fb. Epub 2005 Dec 19.